/
Jounce Therapeutics, Inc.
A clinical-stage biotechnology company focused on developing cancer immunotherapies and predictive biomarkers. It was acquired by Concentra Biosciences in 2023.
Mentions
1 mention · latest on 31 Dec 2023
| Generals and WorkoutsBlog | 2023 Year End Portfolio Review | - | 31 Dec 2023 |